Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.39 |
| ▸ | PTAFR | P25105 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2763050 | 1.00 | CYP4F2 (0.43) | CYP4F2CYP4A11HPGDALOX5ATM | |
| SCHEMBL17049467 | 1.00 | CYP4F2 (0.43) | CYP4F2CYP4A11HPGDALOX5ATM | |
| SCHEMBL13323527 | 0.99 | CYP4F2 (0.44) | CYP4F2CYP4A11HPGDALOX5ATM | |
| SCHEMBL2632342 | 0.95 | HPGD (0.44) | CYP4F2CYP4A11HPGDATMMEN1 | |
| SCHEMBL13324058 | 0.91 | HPGD (0.46) | CYP4F2CYP4A11HPGDATMMEN1 | |
| SCHEMBL16800028 | 0.86 | GPR132 (0.45) | CYP4F2CYP4A11HPGDALOX5SPHK2 | |
| SCHEMBL16800041 | 0.86 | GPR132 (0.45) | CYP4F2CYP4A11HPGDALOX5SPHK2 | |
| SCHEMBL16800026 | 0.86 | GPR132 (0.45) | CYP4F2CYP4A11HPGDALOX5SPHK2 | |
| SCHEMBL20810595 | 0.86 | ALOX5 (0.41) | CYP4F2CYP4A11HPGDALOX5SPHK2 | |
| SCHEMBL16802471 | 0.86 | GPR132 (0.45) | CYP4F2CYP4A11HPGDALOX5SPHK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9120723-B2 | Modulator | CANBEX THERAPEUTICS LIMITED (GB) | 2015-09-01 | — | — | US | disclosed |
| US-9120723-B2 | Modulator | CANBEX THERAPEUTICS LIMITED (GB) | 2015-09-01 | — | — | US | disclosed |